Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Classical hematology 2CNS 2Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Thrombocytopenia 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Liver Neoplasms 1Jacobs syndrome 1

Interventions

Cyclophosphamide 7X-Rays 6Phantoms, Imaging 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Nuclear Medicine Department, Hospital 4Carboplatin 4fludarabine 3Temozolomide 3Nivolumab 3Gemcitabine 3Filgrastim 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2pembrolizumab 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2ensartinib 2belinostat 2Vemurafenib 2Topotecan 2Psychiatric Rehabilitation 2Oxaliplatin 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Thrombopoietin × Gastrointestinal × Clear all
NCT00187109 2008-04-10

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

St. Jude Children's Research Hospital

Phase 1/2 Completed
40 enrolled
CNSClassical hematologyGastrointestinalSarcoma

Jacobs syndrome, Liver Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡